Vesicare LS 5 MG per 5 ML Oral Suspension
- RxCUI
- 2375325
- RxNorm name
- Vesicare LS 5 MG per 5 ML Oral Suspension
- Display name
- Vesicare LS 5 MG per 5 ML Oral Suspension
- Full name
- Vesicare LS 5 MG per 5 ML Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e0300384-e980-45d5-8ed4-48a2618671ae | Vesicare LS 5 MG per 5 ML Oral Suspension | SY | 4 | These highlights do not include all the information needed to use VESICARE LS safely and effectively. See full prescribing information for VESICARE LS. VESICARE LS ® (solifenacin succinate) oral suspension Initial U.S. Approval: 2004 | 20221031 |
| e0300384-e980-45d5-8ed4-48a2618671ae | solifenacin succinate 1 MG/ML Oral Suspension [Vesicare] | SBD | 4 | These highlights do not include all the information needed to use VESICARE LS safely and effectively. See full prescribing information for VESICARE LS. VESICARE LS ® (solifenacin succinate) oral suspension Initial U.S. Approval: 2004 | 20221031 |
| e0300384-e980-45d5-8ed4-48a2618671ae | Vesicare 1 MG/ML Oral Suspension | SY | 4 | These highlights do not include all the information needed to use VESICARE LS safely and effectively. See full prescribing information for VESICARE LS. VESICARE LS ® (solifenacin succinate) oral suspension Initial U.S. Approval: 2004 | 20221031 |
| e0300384-e980-45d5-8ed4-48a2618671ae | VESIcare LS 5 MG in 5 mL Oral Suspension | PSN | 4 | These highlights do not include all the information needed to use VESICARE LS safely and effectively. See full prescribing information for VESICARE LS. VESICARE LS ® (solifenacin succinate) oral suspension Initial U.S. Approval: 2004 | 20221031 |